Health Catalyst, Inc. $HCAT Shares Bought by First Light Asset Management LLC

Key Points

• First Light Asset Management LLC has increased its holdings in Health Catalyst, Inc. by 99.1%, now owning approximately 10,436,807 shares, making it the firm's 6th largest holding.
• Health Catalyst, Inc. has recently seen multiple analysts downgrade its ratings, with price targets significantly lowered; for instance, Citigroup cut its price target from $6.50 to $3.50.
• The current market capitalization of Health Catalyst is approximately $238.55 million, with its shares trading down 7.1% to $3.39.

First Light Asset Management LLC raised its position in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 99.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,436,807 shares of the company's stock after purchasing an additional 5,195,686 shares during the quarter. Health Catalyst accounts for approximately 5.4% of First Light Asset Management LLC's holdings, making the stock its 6th biggest holding. First Light Asset Management LLC owned approximately 14.86% of Health Catalyst worth $47,279,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HCAT. Group One Trading LLC raised its position in Health Catalyst by 107.6% in the 4th quarter. Group One Trading LLC now owns 4,360 shares of the company's stock worth $31,000 after purchasing an additional 2,260 shares during the period. XTX Topco Ltd purchased a new stake in Health Catalyst in the 1st quarter worth about $54,000. Aquatic Capital Management LLC purchased a new stake in Health Catalyst in the 4th quarter worth about $63,000. Brevan Howard Capital Management LP purchased a new stake in Health Catalyst in the 4th quarter worth about $92,000. Finally, MCF Advisors LLC purchased a new stake in Health Catalyst in the 1st quarter worth about $113,000. 85.00% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on HCAT. BTIG Research reissued a "neutral" rating on shares of Health Catalyst in a research report on Friday. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $4.00 target price (down from $9.00) on shares of Health Catalyst in a research report on Friday, August 8th. Wells Fargo & Company reduced their target price on shares of Health Catalyst from $10.00 to $6.00 and set an "overweight" rating on the stock in a research report on Monday, August 11th. Evercore ISI raised their target price on shares of Health Catalyst from $3.00 to $4.00 and gave the stock an "in-line" rating in a research report on Thursday, August 28th. Finally, Summit Redstone set a $5.00 target price on shares of Health Catalyst in a research report on Friday, August 29th. Three research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $4.73.

Health Catalyst Stock Up 2.4%

HCAT stock traded up $0.08 during trading on Friday, hitting $3.38. 789,220 shares of the company's stock traded hands, compared to its average volume of 1,129,022. The firm has a market capitalization of $237.86 million, a P/E ratio of -2.24 and a beta of 1.53. The business has a fifty day simple moving average of $3.59 and a two-hundred day simple moving average of $3.93. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.44. Health Catalyst, Inc. has a 1 year low of $2.52 and a 1 year high of $9.24.

Health Catalyst Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.